The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tsirkin V.I.

Viatskiĭ gosudarstvennyĭ gumanitarnyĭ universitet, Kirov;
Kazanskiĭ gosudarstvennyĭ meditsinskiĭ universitet

Trukhina S.I.

Vyatka State University, Kirov, Russia

Trukhin A.N.

Vyatka State University, Kirov, Russia

Khlybova S.V.

Kafedra akusherstva i ginekologii Instituta poslediplomnogo obrazovaniia Kirovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Anisimov K.Yu.

Department of Obstetrics and Gynecology, Faculty of General Medicine, Ural State Medical University, Yekaterinburg, Russia

Oxytocin receptor agonists and their clinical application

Authors:

Tsirkin V.I., Trukhina S.I., Trukhin A.N., Khlybova S.V., Anisimov K.Yu.

More about the authors

Read: 5382 times


To cite this article:

Tsirkin VI, Trukhina SI, Trukhin AN, Khlybova SV, Anisimov KYu. Oxytocin receptor agonists and their clinical application. Russian Bulletin of Obstetrician-Gynecologist. 2018;18(4):21‑26. (In Russ.)
https://doi.org/10.17116/rosakush201818421

References:

  1. Grigor’eva ME, Golubeva MG. Oxytocin: structure, synthesis, receptors and main effects. Neirohimiya. 2010;27:2:93-101. (In Russ.)
  2. Chernysheva MP, Nozdrachev AD. Nonapeptide oxytocin: somatic and visceral functions in some psychopathologies. Psihofarmakologiya i biologicheskaya narkologiya. 2009;9:3-4:2574-2590. (In Russ.)
  3. Arrowsmith S, Wray S. Oxytocin: its mechanism of action and receptor signalling in the myometrium. J Neuroendocrinol. 2014;26:6: 356-369. PMID: 24888645 https://doi.org/10.1111/jne.12154
  4. Szukiewicz D, Bilska A, Mittal TK, Stangret A, Wejman J, Szewczyk G, Pyzlak M, Zamlynski J. Myometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placenta. BMC Pregnancy Childbirth. 2015;15:220. PMID: 26377392 https://doi.org/10.1186/s12884-015-0656-3
  5. Vrachnis N, Malamas FM, Sifakis S, Deligeoroglou E, Iliodromiti Z. The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. Int J Endocrinol. 2011;2011: art 350546. PMID: 22190926 PMCID: PMC3235456 https://doi.org/10.1155/2011/350546
  6. Ailamazyan EK, Kulakov VI, Radzinskii VE, Savel’eva GM. Akusherstvo. Natsional’noe rukovodstvo. Obstetrics. National guide. Moscow: GEOTAR-Media, 2009;1218. (In Russ.)
  7. Gonser M. Labor induction and augmentation with oxytocin: pharmacokinetic considerations. Arch Gynecol Obstet. 1995;256: 2:63-66. PMID: 7611820 https://doi.org/10.1007/bf00634710
  8. Rydén G, Sjöholm I. Half-life of oxytocin in blood of pregnant and non-pregnant women. Eur J Endocrinol. 1969;61:3:425-431. PMID: 5820054 https://doi.org/10.1530/acta.0.0610425
  9. Adachi S, Oku M. The regulation of oxytocin receptor expression in human myometrial monolayer culture. J Smooth Muscle Res. 1995; 31:4:175-187. PMID: 8589505 https://doi.org/10.1540/jsmr.31.175
  10. Brenninkmeijer CB, Price SA, Lypez Bernal A, Phaneuf S. Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. J Endocrinol. 1999;162:3: 401-408. PMID:10467231 https://doi.org/10.1677/joe.0.1620401
  11. Kimura T, Saji F, Nishimori K, Ogita K, Nakamura H, Koyama M, Murata Y. Molecular regulation of the oxytocin receptor in peripheral organs. J Mol Endocrinol. 2003;30:2:109-115. PMID:12683935
  12. Plested CP, Bernal AL. Desensitisation of the oxytocin receptor and other G-protein coupled receptors in the human myometrium. Experl Physiol. 2001;86:2:303-312. PMID:11429648 https://doi.org/10.1113/eph8602187
  13. Robinson C, Schumann R, Zhang P, Young R. Oxytocin-induced desensitization of the oxytocin receptor. Am J Obstet Gynecol. 2003;188:2:497-502. PMID: 12592262 https://doi.org/10.1067/mob.2003.22
  14. Leikok DF, Vais PG. Osnovy endokrinologii. Fundamentals of Endocrinology. Moscow: Meditsina, 2000;502. (In Russ.)
  15. Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, Graf R, Grauer S, Pulicicchio C, Resnick L, Rahman Z, Sukoff Rizzo SJ, Luo B, Beyer CE, Logue SF, Marquis KL, Hughes ZA, Rosenzweig-Lipson S. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 2010;58:1:69-77. PMID: 19615387 https://doi.org/10.1016/j.neuropharm.2009.07.016
  16. Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Progress in Brain Res. 2008;170:473-512. PMID: 18655903 https://doi.org/10.1016/S0079-6123(08)00437-8
  17. Pitt GR, Batt AR, Haigh RM, Penson AM, Robson PA, Rooker DP, Tartar AL, Trim JE, Yea CM, Roe MB. Non-peptide oxytocin agonists. Bioorganic & Medicinal Chemistry Letters. 2004;14: 17:4585-4589. PMID: 15357997 https://doi.org/10.1016/j.bmcl.2004.04.107
  18. Westergaard JG, Lange AP, Pedersen GT, Secher NJ. Use of oral oxytocics for stimulation of labor in cases of premature rupture of the membranes at term. A randomized comparative study of prostaglandin E2 tablets and demoxytocinresoriblets. Acta Obstetricia et Gynecologica Scandinavica. 1983;62:2:111-116. PMID: 6575576 https://doi.org/10.3109/00016348309155773
  19. Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol. 2009;147:1: 15-20. PMID: 19616358 https://doi.org/10.1016/j.ejogrb.2009.06.018
  20. Dale HH. The action of extracts of the pituitary body. Biochem J. 1909;4:9:427-447. PMID: 16742120 PMCID; PMC1276314 https://doi.org/10.1042/bj0040427
  21. Bell WB. The pituitary body and the therapeutic value of the infundibular extract in shock, uterine atony, and intestinal paresis. Br Med J. 1909;2:2553:1609-1613. PMID: 20764780; PMCID: PMC2321437 https://doi.org/10.1136/bmj.2.2553.1609
  22. Gruber CW, O’Brien M. Uterotonic plants and their bioactive constituents. Planta Medica. 2011;77:3:207-220. PMID: 20845261 https://doi.org/10.1055/s-0030-1250317
  23. Koehbach J, O’Brien M, Muttenthaler M, Miazzo M, Akcan M, Elliott AG, Daly NL, Harvey PJ, Arrowsmith S, Gunasekera S, Smith TJ, Wray S, Göransson U, Dawson PE, Craik DJ, Freissmuth M, Gruber CW. Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proceedings of the National Academy of Sciences USA. 2013;110:52:21183-21188. PMID: 24248349 https://doi.org/10.1073/pnas.1311183110
  24. Kupittayanant S, Munglue P, Lijuan W, Promprom W, Budhaklala N, Wray S. Finding new agents in medicinal plants to act on the myometrium. Exper Physiol. 2014;99:3:530-537. PMID: 4273303 https://doi.org/10.1113/expphysiol.2013.072884
  25. Promprom W, Kupittayanant P, Indrapichate K, Wray S, Kupittayanant S. The effects of pomegranate seed extract and beta-sitosterol on rat uterine contractions. Reprod Sci. 2010;17:3:288-296. PMID: 19966214 https://doi.org/10.1177/1933719109352687
  26. Tripathi V, Stanton C, Anderson FW. Traditional preparations used as uterotonics in Sub-Saharan Africa and their pharmacologic effects. Int J Gynecol Obstet. 2013;120:1:16-22. PMID: 23021290 https://doi.org/10.1016/j.ijgo.2012.06.020
  27. Gran L. An oxytocic principle found in Oldenlandiaaffinis DC An indigenous, Congolese drug kalata-kalata used to accelerate delivery. Medd Nor Farm Selsk. 1970;32:12:173-180.
  28. Gran L. On the effect of a polypeptide isolated from «Kalata-Kalata» (Oldenlandiaaffinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol (Copenh). 1973;33:5:400-408. PMID:4801084
  29. Tsirkin VI, Nozdrachev AD, Toropov AL. The endogenous beta-adrenoceptor sensitizer and its analogs in experiments with rat myometrium reduce the beta-adrenergic blocking effect observed. Doklady RAN. 2010;435:1:131-137. (In Russ.)
  30. Weidmann J, Craik DJ. Discovery, structure, function, and applications of cyclotides: circular proteins from plants. J Experi Botany. 2016;67:16:4801-4812. PMID: 27222514 https://doi.org/10.1093/jxb/erw210
  31. Cranfield CG, Henriques ST, Martinac B, Duckworth P, Craik DJ, Cornell B. Kalata B1 and Kalata B2 Have a Surfactant-Like Activity in Phosphatidylethanolomine-Containing Lipid Membranes. Langmuir. 2017;33:26:6630-6637. PMID: 28605904 https://doi.org/10.1021/acs.langmuir.7b01642
  32. Monji F, Adaikan PG, Lau LC, Bin Said B, Gong Y, Tan HM, Choolani M. Investigation of uterotonic properties of Ananascomosus extracts. J Ethnopharmacol. 2016;193:21-29. PMID: 27426506 https://doi.org/10.1016/j.jep.2016.07.041
  33. Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders. Progress in Brain Res. 2008;170:451-462. PMID: 18655901 https://doi.org/10.1016/S0079-6123(08)00435-4
  34. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology. 2003;28:1:193-198. PMID: 12496956 https://doi.org/10.1038/sj.npp.1300021
  35. Lopatina OL, Furuhara K, Ishihara K, Salmina AB, Higashida H. Communication impairment in ultrasonic vocal repertoire during the suckling period of Cd157 knockout mice: transient improvement by oxytocin. Frontiers in Neuroscience. 2017;11:art. 266. PMID: 28566999 https://doi.org/10.3389/fnins.2017.00266
  36. Macdonald K, Macdonald TM. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harvard Review of Psychiatry. 2010;18:1:1-21. PMID: 20047458 https://doi.org/10.3109/10673220903523615
  37. MacDonald K, Feifel D. Oxytocin’s role in anxiety: a critical appraisal. Brain Research. 2014;1580:22-56. PMID: 24468203 https://doi.org/10.1016/j.brainres.2014.01.025
  38. Munesue T, Nakamura H, Kikuchi M, Miura Y, Takeuchi N, Anme T, Nanba E, Adachi K, Tsubouchi K, Sai Y, Miyamoto K, Horike S, Yokoyama S, Nakatani H, Niida Y, Kosaka H, Minabe Y, Higashida H. Oxytocin for male subjects with autism spectrum disorder and comorbid intellectual disabilities: A Randomized pilot study. Frontiers in Psychiatry. 2016;7:art. 2. PMID: 26834651 https://doi.org/10.3389/fpsyt.2016.00002
  39. Witt DM, Winslow JT, Insel TR. Enhanced social interactions in rats following chronic, centrally infused oxytocin. Pharmacol Biochem Behavior. 1992;43(3):855-861. PMID: 1448480 https://doi.org/10.1016/0091-3057(92)90418-f
  40. Tsirkin VI, Nozdrachev AD, Sizova EN, Polezhaeva TV, Khlybova SV. Jendogennyj sensibilizator beta-adrenoreceptorov (JeSBAR) kak komponent gumoral’nogo zvena avtonomnoj nervnoj sistemy i ego analogi (obzor literatury). Endogenous sensitizer of beta-adrenergic receptors (ESBAR) as a component of the humoral unit of the autonomic nervous system and its analogues (literature review)]. Uspehi fiziologicheskih nauk. 2016;47;4:18-42. (In Russ.)
  41. Tsirkin VI, Anisimov KYu, Bezmel’tseva OM, Bushkova EN, Bratukhina OA, Dmitrieva SL, Cherepanova TV. Oxytocinreactivity of erythrocytes in pregnant women and parturient women and the impact on it of atosiban and dydrogesterone. Vestnik Ural’skoi medicinskoi akademicheskoi nauki. 2017;14:4:399-413. (In Russ.) https://doi.org/10.22138/2500-0918-2017-14-4-399-413
  42. Tsirkin VI, Burova MV, Bushkova EN. The effect of oxytocin and estradiol on erythrocyte sedimentation rate of heparinized venous blood in pregnant women. Biodiagnostika sostoyaniya prirodnykh i prirodno-tehnogennykh sistem: Materialy XV Vserossiiskoi nauchno-prakticheskoi konferentsii s mezhdunarodnym uchastiem. Kirov. 2017;275-280. (In Russ.)
  43. Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, Mouillac B, Corbani M, Guillon G. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol. 2012;24:4:609-628. PMID: 22375852 PMCID; PMC3490377 https://doi.org/10.1111/j.1365-2826.2012.02303.x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.